Abstract
Recently, there has been evidence that alterations in functionality of synapses both at the pre- and postsynaptic level play an important role in the pathogenesis of many neurodegenerative diseases and autism spectrum disorders. Of particular interest may be the data on synaptic defects appearing in the early, asymptomatic stages of the disease, when it might still be possible to prevent mass degeneration of neurons. Probably, modulation of synaptic signal transduction at this stage is very effective through therapy of a number of similar diseases. This review aims to explore the role of synaptic structures in the pathogenesis of Alzheimer's disease, amyotrophic lateral sclerosis and autism spectrum disorders.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
